Skip to content

Clinical trials

Phase 2 Blast Crisis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blast Crisis Phase: Phase 2 Country / region: Germany Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20071

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Bristol-Myers Squibb1
European Organisation for Research and Treatment of Cancer - EORTC1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blast Crisis5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Burkitt Lymphoma2
Hodgkin Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Accelerated Phase2
Leukemia, Myeloid, Acute2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Follicular2

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.